Sagent Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT, and what generic and branded alternatives to SAGENT drugs are available?
SAGENT has eighty-eight approved drugs.
There is one tentative approval on SAGENT drugs.
Drugs and US Patents for Sagent
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204696-002 | Mar 2, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent | VALPROATE SODIUM | valproate sodium | INJECTABLE;INJECTION | 076295-001 | Nov 14, 2002 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 209077-001 | Jul 20, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 209967-002 | Jan 16, 2020 | AP1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-004 | Nov 27, 2015 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Sagent Pharms Inc | LINEZOLID | linezolid | SOLUTION;INTRAVENOUS | 204696-001 | Mar 2, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.